| Metric | Nov 20 | Nov 21 | Nov 22 |
|---|---|---|---|
| Revenue | 66 | 70 | 80 |
| Gross Profit | 39 | 47 | 54 |
| Operating Income | -18 | -25 | -40 |
| Net Income | -23 | -32 | -47 |
| EBITDA | -9 | -17 | -28 |
| EPS Diluted | -0.29 | -0.34 | -0.50 |
| Metric | Nov 20 | Nov 21 | Nov 22 |
|---|---|---|---|
| Cash & Equivalents | 13 | 20 | 24 |
| Total Current Assets | 65 | 92 | 73 |
| Total Assets | 100 | 119 | 93 |
| Total Current Liabilities | 42 | 45 | 114 |
| Total Liabilities | 97 | 101 | 116 |
| Total Equity | 3 | 18 | -23 |
| Total Debt | 55 | 57 | 67 |
| Net Debt | 43 | 36 | 43 |
| Metric | Nov 20 | Nov 21 | Nov 22 |
|---|---|---|---|
| Operating Cash Flow | -14 | -14 | -15 |
| Capital Expenditure | -0 | -0 | -1 |
| Free Cash Flow | -14 | -15 | -16 |
| Stock-Based Comp | 1 | 2 | 4 |
| Net Change in Cash | -16 | 8 | 3 |